Image Placeholder

Graeme Roberts

CONSULTANT HEALTH ECONOMIST

groberts@dhelixc.co.uk
+44(0)20 7299 9830 

Graeme brings 15 years of experience as a health economist both within consultancy and the pharmaceutical industry in roles with SmithKline Beecham and Allergan where he was responsible for the economic strategy for botulinum toxin in Europe. More recently he has worked as an independent consultant running his own business for over 5 years.

Graeme has considerable experience in a number of disease areas including cardiovascular, respiratory, dermatology, oncology, haematology, HIV, hepatitis and neurology. A confident modeler having designed and built economic models in each of the disease areas for inclusion in HTA submissions, early phase scenario analysis and field force models. In addition Graeme has designed and conducted projects in the areas of patient reported outcomes, piggy backing clinical trials, analysis of trial data and post marketing studies. In collaboration with blue chip companies he has published papers and presented conference posters.

Graeme also has a first degree in Biochemistry and an MSc. in Crystallography.